Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 5Phase 2/3 5Phase 3 3Phase 1/2 1Phase 1 1

Status

Recruiting 2Suspended 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Thoracic 1Head & Neck 1Dermatologic 1

Conditions

Lung Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Eyelid Squamous Cell Carcinoma 1

Interventions

pembrolizumab 81Carboplatin 76Magnetic Resonance Spectroscopy 73Specimen Handling 69Cisplatin 62Paclitaxel 55Gemcitabine 46Fluorouracil 37Dexamethasone 37Radiation 36Docetaxel 36Cyclophosphamide 36Radiotherapy 35Pemetrexed 35Doxorubicin 35Oxaliplatin 33Leucovorin 33Bevacizumab 31Capecitabine 28Vincristine 27durvalumab 26Etoposide 24Rituximab 23Taxes 22Irinotecan 22Nivolumab 21Letrozole 21Prednisone 20Biopsy 20Platinum 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Surgical Procedures, Operative × 30 days × Clear all
NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
250 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma

NCT06568172 2026-05-13

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

National Cancer Institute (NCI)

Phase 3 Suspended
420 enrolled
DermatologicHead & NeckSarcoma

Eyelid Squamous Cell Carcinoma

NCT06632327 2026-05-08

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
1,100 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡